Recent meetings
No recorded meetings with EU commissioners.
Mission & Goals
EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities. Taking action for health by enabling access to essential therapies inspires our 3,270 people every day. With strong research and development capabilities and five manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI).
EU Legislative Interests
Critical Medicines Act Health Biotech Act EU Pharmaceutical Legislation EU Pharmaceutical Strategy Critical Medicines Alliance Chemical Regulations
Communication Activities
Participation à la Critical Medicines Alliance : https://health.ec.europa.eu/health-emergency-preparedness-ad-response-hera/overview/criticalmedicines-alliance_en https://health.ec.europa.eu/medicinal-products/legal-framework-governing-medicinal-products-human-use-eu/critical-medicines-act_en
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
CEFIC (https://cefic.org/) including APIC (https://apic.cefic.org/) and EFCG (https://efcg.cefic.org/) France Chimie (https://www.francechimie.fr/) SICOS
Connected Legislation